 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
June 21, 2013 1:49 AM
|
NEJM features IgA nephropathy research from Dr. Robert Wyatt
Science Codex
IgA nephropathy is the most prevalent primary chronic glomerular disease worldwide.
|
|
Scooped by
Gilbert C FAURE
April 11, 2013 2:32 PM
|
Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling - up-to-the-minute news and headlines.
|
|
Scooped by
Gilbert C FAURE
December 23, 2012 3:09 PM
|
As I recently wrote here, IgA nephropathy is an immune glomerulonephritis that causes IgA antibodies to be deposited and trapped in glomeruli, slowly stopping their work. For many years, IgA was considered only as a renal ...
|
|
Scooped by
Gilbert C FAURE
October 31, 2012 4:54 PM
|
Pharmalink Enters Manufacturing Agreement for Nefecon(R)StockhouseNefecon is being developed as the first on-label medication specifically aimed at addressing the underlying pathology of progressive IgA nephropathy, the most common form of primary...
|
|
Scooped by
Gilbert C FAURE
October 12, 2012 10:42 AM
|
A study by Guteirrz and colleagues in JASN, in the current issue, provides insights from long-term follow up in patients with biopsy proven IgA nephropathy with minimal urinary abnormalities. These investigators followed 141 ...
|
|
Scooped by
Gilbert C FAURE
September 3, 2012 6:35 AM
|
Uploaded and shared in Youtube by: mayoclinic — Mayo Clinic' s Dr. Fernando Fervenza, M.D., Ph.D., discusses IgA nephropathy and a new treatment option for those with progressive nephropathy. (Dr.
|
|
Scooped by
Gilbert C FAURE
March 30, 2012 7:39 AM
|
Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J Exp Med. 2012 Mar 26;. Authors: Berthelot L, Papista C, Maciel TT, Biarnes-Pelicot M, Tissandie E, Wang PH, Tamouza H, Jamin ...
|
|
Scooped by
Gilbert C FAURE
January 7, 2012 4:59 AM
|
Pharmalink AB Raises SEK 35 Million Through Share IssueSacramento BeeNefecon is the first pharmaceutical product especially developed for patients with IgA nephropathy, the most common form of primary glomerulonephritis and a cause of end-stage...
|
|
Scooped by
Gilbert C FAURE
January 4, 2012 4:00 AM
|
In the December 2011 issue of American Journal of Kidney Diseases, Jurgen Floege discusses the novel development of pathogenesis of IgA Nephropathy. Test your knowledge with a word search. Clues to the answers are ...
|
|
|
Scooped by
Gilbert C FAURE
June 8, 2013 2:57 PM
|
Following on from yesterday's update on membranous nephropathy, I thought that this would be a good time to give an update on the treatment of another, very common glomerular disease: IgA nephropathy.
|
|
Scooped by
Gilbert C FAURE
January 23, 2013 1:48 PM
|
Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
7thSpace Interactive (press release)
Increased plasma sVCAM-1 is associated with severity in IgA nephropathy.
|
|
Scooped by
Gilbert C FAURE
December 18, 2012 5:06 AM
|
Pharmalink AB, a Swedish specialty pharma company, today announces it has initiated a Phase IIb study with Nefecon (Nefigan) in patients with primary IgA nephropathy at risk of developing end-stage renal disease.
|
|
Scooped by
Gilbert C FAURE
October 31, 2012 4:54 PM
|
Patheon to Manufacture Pharmalink's IgA Nephropathy ProductGenetic Engineering NewsSwedish specialty pharma firm Pharmalink has contracted Patheon to provide development and manufacturing services for its lead clinical-stage product, Nefecon® (PL-56),...
|
|
Scooped by
Gilbert C FAURE
September 29, 2012 2:11 AM
|
The exact pathogenesis is not clear until now and its onset may be related to many factors. At present the more consistent view is that IgA nephropathy is glomerular disease caused by immune complex.
|
|
Scooped by
Gilbert C FAURE
August 8, 2012 7:38 AM
|
IgA nephropathy is the most common primary glomerulonephritis in developed countries. The primary defect lies in the abnormalities of the IgA molecule.
|
|
Scooped by
Gilbert C FAURE
February 7, 2012 9:34 AM
|
Background. IgA nephropathy (IgAN) was thought to be benign but recently found it slowly progresses and leads to ESRD eventually.
|
|
Scooped by
Gilbert C FAURE
January 6, 2012 9:57 AM
|
IgA Nephropathy is the commonest type of Primary Glomerulo-Nephritis(PGN), accounting for about 1/3 of PGN. IgA Nephropathy has the following features: repeated gross hematuria or microscopic hematuria, wide ...
|
|
Scooped by
Gilbert C FAURE
January 4, 2012 4:00 AM
|
IgA Nephropathy is a kind of glomerular disease which has features of mesangial proliferation and prominent sedimentation of IgA in the mesangial area, IgA Nephropathy is common in kids and youngsters, the number of ...
|
Scoop.it!
